|
||||||||||||
CME Information
|
|
|
|
Needs Assessment/Description |
Hypoactive sexual desire disorder (HSDD) is the most prevalent female sexual dysfunction as confirmed by a recent survey of over 2000 postmenopausal women showing 1 in 3 complain of lack of desire. As new drugs are prescribed for men with erectile dysfunction, many women are currently seeking their practitioners’ advice on similar treatments for female sexual dysfunction. Testosterone replacement has been shown to be an effective and safe treatment for the loss of sexual drive in some postmenopausal women. At this time, practitioners debate over how best to manage sexual drive issues in female patients. This activity will discuss how best to manage sexual drive problems in female patients because at this time the FDA does not have an approved drug for HSDD.
Learning Objectives |
At the conclusion of this activity, the participant should be able to:
Identify the components of sexual desire
Identify female sexual dysfunctions with particular focus on hypoactive sexual desire disorder (HSDD)
Target Audience |
back to top |
This CME activity is designed to meet the educational needs of physicians and other health care professionals in the field of women's health.
Method of Participation |
This activity is comprised of three lectures presented in a variety of formats to accommodate the bandwidth and learning preferences of the participant. The activity contains references for further study of this topic.
To receive 2.0 AMA PRA Category 1 Credit(s)™ you should:
-
View the presentations in this CME activity
Complete and submit the posttest, CME registration and activity evaluation forms
The estimated time to complete this activity, including review of the materials is 2.0 hours.
Accreditation/Credit Designation |
back to top |
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Reproductive Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ACCME accredited providers may issue credit to both U.S. and international physicians for any activity that has been designated for AMA PRA Category 1 Credit(s)™ in accordance with PRA requirements.
Term of Approval |
May 2005 through May 2007. Original release date: May 2005
Disclaimer |
This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.
the American Society for Reproductive Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.
Disclosure |
back to top |
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Society for Reproductive Medicine must insure balance, independence, objectivity and scientific rigor in all its educational activities. All presenters must disclose to the learners any commercial interest, financial interest and/or other relationship with manufacturers of pharmaceuticals, laboratory suppliers and/or medical devices. All relationships, whether or not they directly apply to this CME event, must be disclosed. All non-FDA approved uses of products must be clearly identified.
The intent of this disclosure is not to prevent a speaker with a commercial or financial interest from making a presentation. The intent is to assist ASRM in resolving conflicts of interest and to provide learners with information on which they can make their own judgments regarding any bias. Although ASRM reviews and resolves potential conflicts of interest, it remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion.
In addition, contributors have been requested to use generic names for products (drugs/devices), and to include various products within and across classes. If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the question about balance in the CME activity evaluation candidly.
Acknowledgement of Support |
This CME activity is supported by an educational grant from Procter & Gamble Pharmaceuticals.
| back to top |
 | This continuing medical education activity is sponsored by |